Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study
article
OA: bronze
CC0
⤵ 90 in-corpus citations
AI-generated summary
This randomized, double-blind, multicenter, placebo-controlled study evaluated the efficacy and safety of dienogest in treating painful symptoms associated with adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Adenomyosis: Sonohysterography with MRI Correlation via openalex
- Dienogest via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study via openalex
- Hormonal treatments for adenomyosis via openalex
- Influence of Dienogest on Ovulation in Young Fertile Women via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest via openalex
- Transvaginal ultrasound for diagnosis of adenomyosis: a review via openalex
- W2155524713 via openalex
- W2062694026 via openalex
- W2064070315 via openalex
- W2080251208 via openalex
Cited by (50)
- Uterine artery embolization versus dienogest for symptomatic adenomyosis: A randomized controlled trial of short-term efficacy 2026
- Hormonal Treatment for Endometriosis, Adenomyosis, and Fibromatosis 2026
- Efficacy and safety endpoints of dienogest treatment of endometriosis: a systematic review 2025
- Medical treatment for adenomyosis: long term use of progestins 2025
- GnRH analogues and dienogest for second line treatment of endometriosis-associated pain: a systematic review, meta-analysis, and network meta-analysis 2025
- Long-term clinical outcomes of dienogest for perimenopausal women with symptomatic adenomyosis 2025
- Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 2025
- Updates on adenomyosis and fertility 2025
- Results of dienogest treatment and its discontinuation in patients with symptomatic adenomyosis: a prospective cohort study 2025
- Hormonal Treatment of Endometriosis: A Narrative Review 2025
- Effect of Elagolix in comparison to Dienogest in the treatment of symptomatic adenomyosis 2025
- Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society 2025
- Risk factors and countermeasures for abnormal uterine bleeding during dienogest therapy for adenomyosis: a review 2025
- The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis 2024
- A systematic review and Bayesian analysis of the adverse effects of dienogest 2024
- Evaluation of the Efficacy and Safety of Dienogest in the Treatment of Primary Dysmenorrhea: A Study in a District-Level Hospital in Bangladesh 2024
- Factors associated with dysmenorrhoea and menorrhagia improvement in patients with adenomyosis after uterine artery embolisation 2024
- Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation combined with different drugs in the treatment of adenomyosis 2024
- Effect of dienogest treatment on uterine fibroid volume in patients with endometriosis or adenomyosis complicated by uterine fibroids 2024
- Society of Endometriosis and Uterine Disorders forum: adenomyosis today, Paris, France, December 12, 2023 2024
- Contraception et adénomyose 2024
- The effects of vaginal bromocriptine and dienogest on women with adenomyosis: a clinical study 2024
- The Role of Different Medical Therapies in the Management of Adenomyosis: A Systematic Review and Meta-Analysis 2024
- Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023
- Medikamentöse Therapie der Endometriose – ein Update 2023
- Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - A Systematic Review 2023
- In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain 2023
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Clinical Efficacy of Levonorgestrel Releasing Intrauterine System versus Dienogest for Women having Symptomatic Adenomyosis 2023
- Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer 2023
- Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis 2023
- Suture fixation of the levonorgestrel-releasing intrauterine device with hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- The role of the junctional zone in the management of adenomyosis with infertility 2023
- Efficacy and safety of dienogest versus GnRH-a combined with dienogest therapy for adenomyosis 2023
- Current diagnosis and management of adenomyosis in Canada: A survey of Canadian gynaecologists 2022
- Medical Treatment of Adenomyosis 2022
- Research Progress in Drug Treatment of Adenomyosis 2022
- Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer 2022
- Medikamentöse Therapie der Endometriose – ein Update 2022
- Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study 2022
- Prise en charge des ménorragies : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF) 2022
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- Adenomyosis in Reproductive Years: Abnormal Uterine Bleeding and Pain 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Oral Contraceptives 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis 2022
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice 2022
- Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study 2022
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:13.663096+00:00
License: CC0
· commercial use OK